← Eichor
Condition: Indolent Systemic Mastocytosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Indolent Systemic Mastocytosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Phase N/A · 1 location(s) · Blueprint Medicines Corporation · NCT07264959Avapritinib Rollover Study
Phase 4 · 7 location(s) · Blueprint Medicines Corporation · NCT06748001A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Phase N/A · 8 location(s) · Blueprint Medicines Corporation · NCT07255638(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Phase 2/Phase 3 · 71 location(s) · Blueprint Medicines Corporation · NCT04910685
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.